Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease.

"Jee-Fu Huang: Consultant of Roche, BMS, Gilead, Merck, Sysmex, Pharmaessential, Polaris, Aligos, and Instylla. Speaker for Abbvie, BMS, Gilead, Merck, Sysmex, and Roche. Editorial board member of Journal of Clinical and Translational Hepatology since 2022. Chia-Yen Dai: Consultant of Abbvie and Roche; Speaker for Abbvie, Gilead, and Roche. Chung-Feng Huang: Speaker for Abbvie, BMS, Bayer, Gilead, Merck, and Roche. Ming-Lung Yu: Research grant from Abbott, BMS, Merck, and Gilead; Consultant of Abbvie, Abbott, Ascletis, BMS, Merck, Gilead, and Roche; Speaker for Abbvie, Abbott, BMS, Merck, Gilead, and IPSEN. Editorial board member of Journal of Clinical and Translational Hepatology since 2023. Wan-Long Chuang: Consultant of Gilead, AbbVie, BMS, PharmaEssentia, and Aligos; Speaker for Gilead, AbbVie, BMS, and PharmaEssentia. Editorial board member of Journal of Clinical and Translational Hepatology since 2022. The other authors have no conflict of interests related to this publication."

"This study was supported in part by grants from The Ministry of Science and Technology, Taiwan (MOST 110-2314-B-03-073-MY3), The Ministry of Health and Welfare, Taiwan (MOHW, 112-TDU-B-221-124007), National Yang Ming Chiao Tung University-Kaohsiung Medical University Joint Research Project (NYCU-KMU-111-I001, NYCU-KMU-112-I001), and Kaohsiung Medical University Hospital (KMUH SA10907, KMUH110-0R05)."